Login / Signup

Communicating Alzheimer's biomarker results to cognitively unimpaired research participants: Satisfaction, utility, and impact on research attitudes.

Claire M EricksonFred B KetchumKristin E BascheNathaniel A ChinMarcella L EvelerLindsay R Clark
Published in: Alzheimer's & dementia (New York, N. Y.) (2024)
Participants wanted to learn their amyloid results to contribute to research.Satisfaction with disclosure and post-disclosure visits was high overall.Returning AD biomarkers can increase willingness to participate in research.
Keyphrases
  • cognitive decline
  • mild cognitive impairment
  • mental health